A Study to Develop a Novel Methodology to Quantify Hepatic Fat Content in Humans

Overview

About this study

The purpose of this study is to develop a novel methodology to quantify hepatic fat content in humans. This is a pilot study aimed at gathering data for inter and intra scan variability.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Healthy overweight subjects with normal fasting plasma glucose between the ages of 30 - 50 years with BMI >28 or < 40 kg/m2 will be included.
- Healthy will indicate that they generally are in good health and have no chronic medical condition that may potentially impact the outcome measures.
Medications (thyroid, statins, antihypertensive medications that are metabolically neutral (e.g. low dose thiazides) will be permitted.
All patients undergoing hepatic resection for certain diseases e.g. hepato biliary cancer undergo routine MRI for clinical diagnostic purposes

Exclusion Criteria:

We will not include women who are pregnant in this study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Rita Basu, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Rita Basu, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials